Aripiprazole Lauroxil-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aripiprazole Lauroxil

Published:2017-06 Issue:3 Volume:37 Page:289-295
ISSN:1533-712X
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:J Clin Psychopharmacol

Author:

Hard Marjie L.,Mills Richard J.,Sadler Brian M.,Turncliff Ryan Z.,Citrome Leslie

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference20 articles.

1. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis;Lancet,2012

2. Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response;J Clin Psychiatry,2009

3. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care;J Clin Psychiatry,2006

4. Practice guideline for the treatment of patients with schizophrenia, second edition;Am J Psychiatry,2004

5. A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder;Neuropsychiatr Dis Treat,2006

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Employing Bayesian analysis to establish a cut-off point and assess stigma prevalence in substance use disorder: a comprehensive study of the Chinese version of the Substance Use Stigma Mechanism Scale;Social Psychiatry and Psychiatric Epidemiology;2024-02-27

2. Long-Acting Injectable Antipsychotics—A Review on Formulation and In Vitro Dissolution;Pharmaceutics;2023-12-24

3. Prodrugs: Harnessing chemical modifications for improved therapeutics;Journal of Drug Delivery Science and Technology;2023-12

4. Hot Melt Extrusion as a Formulation Method of Terpolymer Rods with Aripiprazole: A Preliminary Study;Applied Sciences;2023-08-23

5. Employing Bayesian Analysis to Establish a Cut-off Point and Assess Stigma Prevalence in Substance Use Disorder: A Comprehensive Study of the Chinese Version of the Substance Use Stigma Mechanism Scale;2023-08-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3